A Study to Evaluate the Drug Levels of Mezigdomide in Adult Participants With Renal Impairment

Clinical trial NCT06318676 · COMPLETED

Trial details

NCT number: NCT06318676
Sponsor: Celgene
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Renal Impairment

Start date: 2024-03-21
Primary completion: 2024-11-15
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.